Dr. Joyce Ridgeway Foresman-capuzzi, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 844 13th Ave, Prospect Park, PA 19076 Phone: 610-505-3792 |
News Archive
Roche and Inovio Pharmaceuticals, Inc. announced today that they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio's highly-optimized, multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B.
The incidence of infective endocarditis did not increase after American guidelines for antibiotic use before dental procedures were updated in 2007, a report in Circulation shows.
There's little question about the value of breast milk as a source of infant nutrition, but a University at Buffalo sociologist is part of a research team whose new study is adding critical nuance toward better understanding the association between breastfeeding and infant health in the first year of life.
A targeted approach to treating toxoplasmosis, a parasitic disease, shows early promise in test-tube and animal studies, where it prevented the parasites from making selected proteins. When tested in newly infected mice, it reduced the number of viable parasites by more than 90 percent, researchers from the University of Chicago Medicine report in the Proceedings of the National Academy of Sciences.
CytomX Therapeutics, a biotechnology company focused on the development of proteolytically activated antibodies, today announced the receipt of two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The grants are directed toward the company's lead preclinical programs targeting colon, head and neck, pancreatic and triple-negative breast cancers and glioblastoma multiforme (GBM).
› Verified 2 days ago